Youngwu Kim, MD
Urogynecology and Reconstructive Pelvic Surgery · Boston, MANPI 1952797268
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 38.2% of the total.
Across 71 payments — averaging $202.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Boston Scientific$2K
- Davol Inc.$2K
- Hologic Sales And Service, LLC$2K
- Intuitive Surgical$1K
- Axonics, Inc.$902
- plus $1K from 4 others
What the payments were for
- Consulting fees$6,17543%
- Speaking & faculty fees$2,00014%
- Travel & lodging$6485%
- Food & beverage$4,53431%
- Education$1,0477%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $5,509 |
| Boston Scientific | 28 | $2,277 |
| Davol Inc. | 1 | $2,000 |
| Hologic Sales And Service, LLC | 2 | $1,575 |
| Intuitive Surgical | 3 | $1,058 |
| Axonics, Inc. | 9 | $902 |
| Bolder Surgical, LLC | 1 | $675 |
| AbbVie | 2 | $225 |
| Dilon Technologies, Inc. | 1 | $138 |
| Urovant Sciences Inc | 1 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLUENT FLUID MANAGEMENT SYSTEM$1,575
- DAVINCI XI$1,000
- CoolSeal Generator$675
- Bulkamid$674
- Axonics$601
- INTERSTIM$599
- ALTAVIVA$450
- UPSYLON$396
- Advantage System$324
- Solyx SIS System$268
- GENERAL FEMALE SUI$223
- HemoBlast Bellows$138
- BOTOX$125
- SOLYX$123
How this compares
$14,405 in reported general payments places this provider in the 75th percentile of 35 urogynecology and reconstructive pelvic surgery providers in Massachusetts.
See all urogynecology and reconstructive pelvic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 100 | $78,011 |
| MyrbetriqMirabegron | 91 | $51,395 |
| Estradiol | 207 | $14,217 |
| Mirabegron ErMirabegron | 18 | $6,463 |
| YuvafemEstradiol | 19 | $3,452 |
| Clobetasol Propionate | 12 | $1,590 |
| Methenamine Hippurate | 26 | $1,294 |
| Trospium Chloride | 20 | $1,131 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 44 | $482 |
| Solifenacin Succinate | 13 | $168 |
| Oxycodone Hcl | 36 | $72 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $57 |
| Ibuprofen | 16 | $47 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Boston
- Lori JonesBoston$22K
- John Al JamalBoston$15K
- Tsung MouBoston$10K
- Evelyn HallBoston$6K
- Roger LefevreBoston$5K
- May WakamatsuBoston$4K
- Milena WeinsteinBoston$4K
- Edward KimBoston$3K
- Mallika AnandBoston$443
- Gnankang NapoeBoston$28
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.